Mycronic revenue and financials

MYCR · Nasdaq Stockholm · SEK

kr 355.00Change from previous close: −0.89%Absolute change: −kr 3.20

Close · October 5, 2026

In the fiscal year ended December 2025, Mycronic reported revenue of kr 7.94B (+12.48% year over year). Net income was kr 1.56B, a net margin of 19.7%.

Annual revenue · 2025: kr 7.94B
  1. kr 5.12B2022
  2. kr 5.71B2023
  3. kr 7.06B2024
  4. kr 7.94B2025

Fiscal year ending in December. Sources and method on the page Methodology and sources.

At a glance

Revenue growth
+12.48%
2025 vs 2024
Net income growth
−7.31%
2025 vs 2024
Net margin
19.7%
2024: 23.8%

Financial data

Amounts in millions of SEK; per-share values in SEK; shares in millions.

Income statement · Annual
Item20252024202320222021
Total revenue7,9387,0575,7065,119—
Cost of revenue3,7743,3382,8502,831—
Gross profit4,1633,7192,8552,288—
Selling, general and administrative447338407286—
Research and development978747653638—
Operating income2,0172,0141,251895—
EBIT1,9872,0991,275903—
EBITDA2,3172,3651,5391,156—
Interest expense17.015.013.013.0—
Pre-tax income1,9702,0841,262890—
Income tax410396266154—
Net income1,5601,683998741—
Net income to common shareholders1,5601,683998741—
Basic EPS7.998.625.113.80—
Diluted EPS7.998.625.113.80—
Average shares (basic)195195195195—
Average shares (diluted)195195195195—